The Indian Pharmaceuticals sector has come a long way, being almost non-existent during 1970, to a prominent provider of health care products, meeting almost 95% of country's pharmaceutical needs. London research company Global Insight estimates that India's share of the global generics market will have risen from 4% to 33% by 2007. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Indian market. India's US$ 3.1 billion pharmaceutical industry is growing at the rate of 14 percent per year. It is one of the largest and most advanced among the developing countries. The Indian Pharmaceutical Industry today is in the front rank of India's science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured.
[...] Also in developing countries like India, the traditional medicines also play a major substituting role INTENSITY OF RIVALRY: the Indian Pharmaceutical industry is highly fragmented with around 250-300 manufacturing & formulation units in the organized sector which contribute to only 70% of the market share of the total sales in the country. The concentration ratio (proportion of total industry output by the largest firm in the industry) for the industry is very low. Also government subsidies have led to the proliferation of many small players. [...]
[...] FEW TOP COMPANIES RANBAXY India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. The Company is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharmaceuticals markets of the world. The Company with a global footprint in 49 countries, world-class manufacturing facilities in 11 and a diverse product portfolio, is rapidly moving towards global leadership, riding on its success in the world's emerging and developed markets. [...]
[...] IMPACT OF UNION BUDGET 2008-09 ON INDIAN PHARMACEUTICALS SECTOR Budget provisions for Pharmaceuticals industry were: 1. Cut in excise duty to from Major beneficiary on account of cut in excise duty is the MNC pharmaceuticals companies as they get higher proportion of their revenue from domestic markets compared to home growth companies Weighted deduction of 125% on any payment made to companies engaged in The contract research which is on take off in the county has got a boost by way of weighted deduction of 125% on any payment made to companies engaged in R&D The allocation under ‘National Rural Health Mission' has been increased to Rs 12,050 crore 4. [...]
[...] The pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023. India has had a strong domestic pharmaceutical industry and a rapidly expanding market with a population of over a billion and a rapidly expanding economy. Prevalence values of many diseases are likely to increase with expansion of population, urbanization and with higher identification rates in the coming decade. [...]
[...] The Indian pharmaceutical industry has a unique amalgamation of three critical factors which make it so attractive for investment thereby adding to impetus growth. Top 10 Pharmaceuticals in India Rank Company Revenue 2008 (Rs crore) Revenue 2008 (USD millions) Ranbaxy Sun 2,375 Pharmaceutical s Dr. Reddy's 1,933 Laboratories Cipla Aurobindo Pharma GlaxoSmithKli ne Lupin Laboratories Cadila Healthcare Wockhardt The process patent regime Price controls Exemptions to Small Scale Industries (SSIs). INDUSTRY STRUCTURE The structure of the Indian Pharmaceutical Industry is characterized by fragmentation, with over 20,000 players a large number of them in the small scale sector, only 260 in the organized sector. [...]
Online readingwith our online reader
Content validatedby our reading committee